Geftinat Gefitinib – 250 mg (1 pack / 30 tablets)

Buy Geftinat 250 mg Gefitinib Tablets Online

Geftinat Gefitinib – 250 mg (1 pack / 30 tablets)

At a Glance

Generic Name: Gefitinib

Brand Name: Geftinat

Strength & Pack Size: Geftinat 250 mg tablets – 1 pack / 30 tablets

Dosage Form: Oral film-coated tablets

Therapeutic Class: EGFR tyrosine kinase inhibitor, targeted anticancer therapy

Main Indication: Advanced or metastatic non-small cell lung cancer (NSCLC) with sensitising EGFR mutations

Use in Therapy: First-line or subsequent-line targeted treatment under specialist oncology guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Geftinat 250 mg is a generic gefitinib tablet used as targeted therapy in selected adults with advanced or metastatic
non-small cell lung cancer (NSCLC). Many NSCLC tumours, especially adenocarcinomas, carry activating EGFR mutations that make cancer cells strongly dependent on
EGFR signalling for growth and survival. Geftinat 250 mg gefitinib tablets are designed to inhibit this pathway and help slow disease progression in EGFR-mutation–positive lung cancer
under the supervision of an experienced oncology team.

Each Geftinat tablet contains 250 mg gefitinib, the standard oral dose used in most gefitinib protocols worldwide.
The convenient 1 pack / 30 tablets presentation usually corresponds to about one month of once-daily treatment, allowing patients and caregivers to align
Geftinat orders with monthly clinic visits and imaging. As a generic gefitinib 250 mg product, Geftinat contains the same active ingredient and strength as the originator brand,
while often being more accessible in USD for long-term targeted therapy.

Geftinat 250 mg gefitinib tablets are normally prescribed only after molecular testing has confirmed that the tumour carries a sensitising EGFR mutation.
In some settings, Geftinat gefitinib is used as first-line systemic therapy in EGFR-positive NSCLC; in others it is given after chemotherapy, depending on current guidelines.
Generic Meds Mart does not decide whether you should receive gefitinib; we supply Geftinat 250 mg in the strength and quantity that match your written treatment plan.

Key Uses

Geftinat 250 mg gefitinib tablets are typically used under specialist supervision for:

• Advanced or metastatic non-small cell lung cancer (NSCLC), usually adenocarcinoma, with documented sensitising EGFR mutations
• First-line targeted therapy in EGFR-mutation–positive NSCLC where gefitinib is recommended by national or international guidelines
• Subsequent-line targeted therapy in selected patients whose disease remains suitable for EGFR inhibitor treatment after previous systemic therapy

Your oncologist will decide whether Geftinat 250 mg is appropriate based on mutation status, previous treatments, performance status and co-existing illnesses.

How Gefitinib Works in Chemotherapy

Gefitinib is a targeted anticancer medicine from the class of EGFR tyrosine kinase inhibitors.
Unlike classic cytotoxic chemotherapy, Geftinat gefitinib does not directly damage DNA. Instead, it selectively blocks the intracellular tyrosine kinase activity of the
epidermal growth factor receptor (EGFR), which is a critical driver of growth in many EGFR-mutated tumours.

In EGFR-positive NSCLC, constitutively active EGFR triggers downstream signalling through pathways such as RAS/RAF/MEK/ERK and PI3K/AKT, promoting tumour cell proliferation and survival.
By binding to the ATP-binding site of the EGFR tyrosine kinase, Geftinat 250 mg reduces receptor phosphorylation and interrupts these signals.
This deprives tumour cells of key proliferative and anti-apoptotic stimuli, so they are more likely to slow growth or undergo programmed cell death.

Because EGFR is also expressed in normal skin and gastrointestinal epithelium, gefitinib therapy can lead to characteristic side effects such as rash and diarrhea,
which require regular monitoring and supportive care.

Dosage & Administration

The dose and schedule of Geftinat 250 mg must always follow your oncology team’s instructions and current guidelines.
In many protocols, the usual adult dose is one Geftinat 250 mg tablet taken once daily, but only your treating specialists can confirm the correct regimen and duration.

• Take Geftinat tablets once daily at roughly the same time each day, with a glass of water.
• Swallow Geftinat 250 mg whole; do not crush, split or chew the tablet unless your pharmacist gives specific instructions.
• Follow your clinic’s advice on taking gefitinib with or without food and aim for a consistent daily routine.
• Do not change your daily dose, interrupt therapy or take extra tablets without clear guidance from your oncology team.
• If you miss a dose, follow the written instructions from your treatment centre; do not double the next dose unless your doctor tells you to.

Regular clinic visits, blood tests and imaging help your doctors assess response and decide whether your dose of Geftinat 250 mg gefitinib should continue or be adjusted.

Precautions

Before starting Geftinat 250 mg gefitinib tablets, inform your healthcare team about your full medical history and all prescription medicines, over-the-counter products and herbal supplements you use.
Key precautions include:

• Pre-existing liver disease or abnormal liver function tests
• History of interstitial lung disease, pulmonary fibrosis or chronic lung conditions
• Use of strong CYP3A4 inducers or inhibitors that may alter gefitinib blood levels
• Use of gastric acid–reducing medicines that can affect gefitinib tablet absorption
• Pregnancy or breastfeeding; Geftinat gefitinib is not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Geftinat 250 mg therapy, as directed by their oncologist.

Gefitinib Side Effects

Common side effects

Common side effects of Geftinat 250 mg gefitinib tablets may include:

• Acne-like skin rash on the face, scalp and upper torso
• Dry skin, itching or mild redness
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Mild mouth sores or irritation in the mouth or throat
• Fatigue or a general feeling of low energy
• Mild elevations in liver enzymes on blood tests

These effects are often manageable with supportive care, dermatologic treatments and, when necessary, dose interruptions or adjustments as decided by your oncology team.

Serious side effects

Less common but serious side effects of gefitinib require urgent medical attention and may include:

• New or rapidly worsening shortness of breath, cough and fever suggesting interstitial lung disease or severe pneumonitis
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, persistent upper abdominal pain
• Severe or prolonged diarrhea leading to dehydration and dizziness
• Severe skin reactions with blistering, peeling or painful widespread rash
• Sudden chest pain, severe breathlessness or other acute symptoms suggesting cardiovascular or pulmonary complications

If you experience any of these symptoms while taking Geftinat 250 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Geftinat 250 mg gefitinib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton, protected from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use Geftinat after the expiry date printed on the packaging.

Ask your pharmacist or oncology centre how to safely dispose of unused or expired Geftinat gefitinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart provides safe, structured access to key oncology medicines such as
Geftinat 250 mg gefitinib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a verifiable export record.

When you buy Geftinat online from Generic Meds Mart, you benefit from:

• Original gefitinib 250 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured information about Geftinat gefitinib tablets to support discussions with your oncology team
• Support for ordering, payment and delivery questions

Order Now

Geftinat 250 mg gefitinib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Geftinat online, ensure your oncologist has confirmed an EGFR-mutation–positive tumour, recommended gefitinib as part of your treatment plan and specified the daily dose and expected duration.

Select Geftinat 250 mg (1 pack / 30 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.